ES2151716T3 - Derivados peptidos. - Google Patents

Derivados peptidos.

Info

Publication number
ES2151716T3
ES2151716T3 ES97903488T ES97903488T ES2151716T3 ES 2151716 T3 ES2151716 T3 ES 2151716T3 ES 97903488 T ES97903488 T ES 97903488T ES 97903488 T ES97903488 T ES 97903488T ES 2151716 T3 ES2151716 T3 ES 2151716T3
Authority
ES
Spain
Prior art keywords
derivatives
invention refers
peptidic derivatives
peptided
peptidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97903488T
Other languages
English (en)
Inventor
Ronald Cotton
Philip Neil Edwards
Richard William Arthur Luke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603855.9A external-priority patent/GB9603855D0/en
Priority claimed from GBGB9620819.4A external-priority patent/GB9620819D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ES2151716T3 publication Critical patent/ES2151716T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

LA INVENCION SE REFIERE A DERIVADOS PEPTIDICOS UTILES, DE FORMULA (I): P - R 1 - R 2 - R 3 - R 4 , EN DONDE P, R 1 , R 2 , R 3 Y R 4 TIENEN LOS DIVERSOS SIGNIFICADOS DEFINIDOS EN LA DESCRIPCION, Y A SUS SALES FARMACEUTICAMENTE ACEPTABLES Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. DICHOS DERIVADOS PEPTIDICOS NUEVOS, SON VALIOSOS PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS O AUTOINMUNES MEDIADAS POR LAS CELULAS T, DEPENDIENTES DE MHC DE CLASE II, COMO LA ARTRITIS REUMATOIDE. LA INVENCION SE REFIERE ADEMAS A LOS PROCEDIMIENTOS DE FABRICACION DE DICHOS DERIVADOS PEPTIDICOS Y A LA UTILIZACION DE DICHOS COMPUESTOS EN TRATAMIENTOS MEDICOS.
ES97903488T 1996-02-23 1997-02-18 Derivados peptidos. Expired - Lifetime ES2151716T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603855.9A GB9603855D0 (en) 1996-02-23 1996-02-23 Peptide derivatives
GBGB9620819.4A GB9620819D0 (en) 1996-10-05 1996-10-05 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2151716T3 true ES2151716T3 (es) 2001-01-01

Family

ID=26308795

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97903488T Expired - Lifetime ES2151716T3 (es) 1996-02-23 1997-02-18 Derivados peptidos.

Country Status (29)

Country Link
US (1) US6087336A (es)
EP (1) EP0882066B1 (es)
JP (1) JP3468528B2 (es)
KR (1) KR19990087123A (es)
CN (1) CN1116305C (es)
AR (1) AR005974A1 (es)
AT (1) ATE196152T1 (es)
AU (1) AU722877C (es)
BR (1) BR9707720A (es)
CA (1) CA2242809A1 (es)
CZ (1) CZ266398A3 (es)
DE (1) DE69703032T2 (es)
DK (1) DK0882066T3 (es)
ES (1) ES2151716T3 (es)
GB (1) GB9702377D0 (es)
GR (1) GR3034361T3 (es)
HK (1) HK1015383A1 (es)
HR (1) HRP970099B1 (es)
HU (1) HU222198B1 (es)
ID (1) ID16037A (es)
IL (1) IL125804A0 (es)
NO (1) NO983849L (es)
NZ (1) NZ330944A (es)
PL (1) PL328486A1 (es)
PT (1) PT882066E (es)
SK (1) SK114998A3 (es)
TR (1) TR199801614T2 (es)
TW (1) TW492978B (es)
WO (1) WO1997031023A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
WO1997046578A1 (en) 1996-06-07 1997-12-11 Zeneca Limited Peptide derivatives
GB9621836D0 (en) * 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) * 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
GB9625865D0 (en) * 1996-12-12 1997-01-29 Zeneca Ltd Peptides
GB9809021D0 (en) 1998-04-29 1998-06-24 Zeneca Ltd Chemical process
US6262080B1 (en) 1998-12-31 2001-07-17 Avantis Pharmaceuticals Inc. 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase
AU1926700A (en) * 1998-12-31 2000-07-24 Aventis Pharmaceuticals Inc. 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
GB9912911D0 (en) * 1999-06-04 1999-08-04 Zeneca Ltd Chemical process
US6485740B1 (en) * 2000-03-14 2002-11-26 Yutoku Pharmaceutical Ind., Co., Ltd. Transdermal methotrexate preparations
GB0017979D0 (en) * 2000-07-22 2000-09-13 Astrazeneca Ab Chemical process
GB0130285D0 (en) 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0317733D0 (en) 2003-07-29 2003-09-03 Novartis Ag Organic compounds
EP2366448B1 (en) * 2010-03-16 2016-07-27 Amminex Emissions Technology A/S Method and device for controlled dosing of a gas with fluctuating supply pressure

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) * 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
US4680283A (en) * 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
DE3711335A1 (de) * 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5331089A (en) * 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
WO1992002543A1 (en) * 1990-08-01 1992-02-20 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
AU2468392A (en) * 1991-08-29 1993-04-05 Cytel Corporation Novel immunosuppressants
DK0644197T3 (da) * 1993-06-04 1999-06-07 Vertex Pharma Peptidphosphinyloxymethylketoner som inhibitorer af interleukin-1beta-konverterende enzymer
AU698962B2 (en) * 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
AU2238395A (en) * 1994-04-01 1995-10-23 Immulogic Pharmaceutical Corporation Haptenated peptides and uses thereof
JPH10508035A (ja) * 1995-03-24 1998-08-04 モレキュメティックス リミテッド βシート模倣物およびプロテアーゼインヒビターとしてのその使用
US5719296A (en) * 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
WO1997016425A1 (en) * 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
TR199801614T2 (xx) 1998-11-23
NO983849L (no) 1998-10-21
JP2000508623A (ja) 2000-07-11
JP3468528B2 (ja) 2003-11-17
HU222198B1 (hu) 2003-05-28
NO983849D0 (no) 1998-08-21
EP0882066A1 (en) 1998-12-09
CN1116305C (zh) 2003-07-30
KR19990087123A (ko) 1999-12-15
PL328486A1 (en) 1999-02-01
DK0882066T3 (da) 2000-12-18
DE69703032D1 (de) 2000-10-12
PT882066E (pt) 2000-12-29
CA2242809A1 (en) 1997-08-28
AR005974A1 (es) 1999-07-21
HUP9901189A2 (hu) 1999-08-30
AU722877C (en) 2002-12-05
NZ330944A (en) 2000-04-28
ATE196152T1 (de) 2000-09-15
AU722877B2 (en) 2000-08-10
HRP970099A2 (en) 1998-04-30
US6087336A (en) 2000-07-11
GB9702377D0 (en) 1997-03-26
HRP970099B1 (en) 2001-10-31
HUP9901189A3 (en) 2000-07-28
SK114998A3 (en) 1999-02-11
IL125804A0 (en) 1999-04-11
EP0882066B1 (en) 2000-09-06
ID16037A (id) 1997-08-28
GR3034361T3 (en) 2000-12-29
AU1803597A (en) 1997-09-10
DE69703032T2 (de) 2001-04-12
CZ266398A3 (cs) 1998-11-11
HK1015383A1 (en) 1999-10-15
TW492978B (en) 2002-07-01
BR9707720A (pt) 1999-04-06
CN1213379A (zh) 1999-04-07
WO1997031023A1 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
ES2151716T3 (es) Derivados peptidos.
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2161290T3 (es) Derivados de quinazolina.
ES2183937T3 (es) Inhibidores de la adhesion celular.
SV1998000029A (es) Compuestos de pirazina ref. pg3186
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
AR026410A1 (es) ''2-aril-3-(heteroaril)-imidazo[1,2-a]pirimidinas sustituidas, y las composiciones y metodos farmaceuticos relacionados
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
PA8452001A1 (es) Derivados de macrolidos c-4" sustituidos
UY27981A1 (es) Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf)
AR008878A1 (es) Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
CR7743A (es) Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf)
PA8583101A1 (es) Nuevos compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf)
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
ES2182161T3 (es) Utilizacion de derivados de pirimidina para la preparacion de un medicamento para la prevencion del cancer.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
TR199802537T2 (xx) Peptit t�revleri.
ES2072263T3 (es) Derivados de 4-aminopiridina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 882066

Country of ref document: ES